R01 CA231219/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2018	6
2019	11
2020	3
2021	3
2022	2
2023	3
2024	0

1

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy.

Kelkar S, Oyekunle T, Eisenberg A, Howard L, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Klaassen Z, Terris MK, Freedland SJ, Csizmadi I. Kelkar S, et al. JNCI Cancer Spectr. 2021 Mar 9;5(3):pkab023. doi: 10.1093/jncics/pkab023. eCollection 2021 Jun. JNCI Cancer Spectr. 2021. PMID: 34169227 Free PMC article.

2

Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.

Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR, Song DY, Sun Y, Mehra R, Kaffenberger SD, Morgan TM, Nguyen PL, Feng FY, Sharma V, Tran PT, Stish BJ, Pisansky TM, Zaorsky NG, Moraes FY, Berlin A, Finelli A, Fossati N, Gandaglia G, Briganti A, Carroll PR, Karnes RJ, Kattan MW, Schipper MJ, Spratt DE. Dess RT, et al. JAMA Oncol. 2020 Dec 1;6(12):1912-1920. doi: 10.1001/jamaoncol.2020.4922. JAMA Oncol. 2020. PMID: 33090219 Free PMC article.

3

Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population.

Zhao H, Howard LE, De Hoedt AM, Terris MK, Amling CL, Kane CJ, Cooperberg MR, Aronson WJ, Klaassen Z, Polascik TJ, Vidal AC, Freedland SJ. Zhao H, et al. Prostate. 2021 May;81(7):390-397. doi: 10.1002/pros.24115. Epub 2021 Mar 11. Prostate. 2021. PMID: 33705584

4

Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120.

Liang P, Henning SM, Grogan T, Elashoff D, Said J, Cohen P, Aronson WJ. Liang P, et al. Prostate Cancer Prostatic Dis. 2023 Oct 23:10.1038/s41391-023-00745-4. doi: 10.1038/s41391-023-00745-4. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37872251

5

Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.

Sergeyev A, Gu L, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Klaassen Z, Terris MK, Guerrios-Rivera L, Freedland SJ, Csizmadi I. Sergeyev A, et al. Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1208-1216. doi: 10.1158/1055-9965.EPI-22-1324. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37294698 Free PMC article.

6

Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database.

Yirga A, Oyekunle T, Howard LE, De Hoedt AM, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Klaanssen Z, Freedland SJ, Vidal AC. Yirga A, et al. Cancer Causes Control. 2021 Feb;32(2):189-197. doi: 10.1007/s10552-020-01373-2. Epub 2021 Jan 4. Cancer Causes Control. 2021. PMID: 33392907 Free PMC article.

7

Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?

Klaassen Z, Howard L, Wallis CJD, Janes JL, De Hoedt A, Aronson WJ, Polascik TJ, Amling CJ, Kane CJ, Cooperberg MR, Terris MK, Wu Y, Freedland SJ. Klaassen Z, et al. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):151-155. doi: 10.1038/s41391-022-00585-8. Epub 2022 Sep 1. Prostate Cancer Prostatic Dis. 2023. PMID: 36050455

8

Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer.

Whitney CA, Howard LE, Freedland SJ, DeHoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Daskivich TJ. Whitney CA, et al. Prostate Cancer Prostatic Dis. 2019 May;22(2):252-260. doi: 10.1038/s41391-018-0095-0. Epub 2018 Oct 2. Prostate Cancer Prostatic Dis. 2019. PMID: 30279582

9

Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120.

Liang P, Henning SM, Grogan T, Elashoff D, Ye H, Cohen P, Aronson WJ. Liang P, et al. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):539-546. doi: 10.1038/s41391-021-00440-2. Epub 2022 Jan 24. Prostate Cancer Prostatic Dis. 2022. PMID: 35075215 Free PMC article.

10

Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.

Freedland SJ, Branche BL, Howard LE, Hamilton RJ, Aronson WJ, Terris MK, Cooperberg MR, Amling CL, Kane CJ; SEARCH Database Study Group. Freedland SJ, et al. BJU Int. 2019 Jul;124(1):69-75. doi: 10.1111/bju.14594. Epub 2018 Nov 16. BJU Int. 2019. PMID: 30347135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year